Affimed N.V.

NASDAQ: AFMD
Share price (3/25/25): $0.88
Market cap (3/25/25): $13.4 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

ended 12/31/20 FY 2020 – amended

ended 12/31/20 FY 2020

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

683 Capital Management, LLC

683 Capital Management, LLC

Ridgeback Capital Investments L.P.

683 Capital Management, LLC

BlackRock Finance, Inc.

News Filter

Reports Positive Clinical Update on AFM24/Atezolizumab Combination Therapy in Non-Small Cell Lung Cancer

Unaudited Consolidated Interim Statements of Comprehensive Loss

Annual General Meeting Results

Text Advertisement Convocation EGM 2024

0001608390--12-312024Q2false2024-06-300.100000000562000800000

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Notice of effectiveness